433 related articles for article (PubMed ID: 1672289)
21. A high-resolution meiotic mapping panel for the pericentromeric region of chromosome 10.
Lichter JB; Wu J; Miller D; Goodfellow PJ; Kidd KK
Genomics; 1992 Jul; 13(3):607-12. PubMed ID: 1353475
[TBL] [Abstract][Full Text] [Related]
22. Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.
Morrison PJ; Hadden DR; Hughes AE; Kennedy L; Russell CJ; Nevin NC
Q J Med; 1991 Jul; 80(291):597-603. PubMed ID: 1682970
[TBL] [Abstract][Full Text] [Related]
23. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Decker RA
Surgery; 1993 Dec; 114(6):1059-63. PubMed ID: 7903002
[TBL] [Abstract][Full Text] [Related]
24. A kindred of multiple endocrine neoplasia type 2B.
Yamamoto S; Morimoto I; Fujihira T; Watanabe K; Zeki K; Yoshimoto K; Zeze F; Eto S
Endocrinol Jpn; 1992 Feb; 39(1):25-30. PubMed ID: 1351466
[TBL] [Abstract][Full Text] [Related]
25. A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locus.
Lairmore TC; Dou S; Howe JR; Chi D; Carlson K; Veile R; Mishra SK; Wells SA; Donis-Keller H
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):492-6. PubMed ID: 8093642
[TBL] [Abstract][Full Text] [Related]
26. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
27. [Endocrine polyadenomatosis of 2a type (MEN 2a). Clinical and genetic study of a family].
Guillausseau PJ; Guillausseau C; Calmettes C; Feingold N; Demenais F; Sobol H; Gony J; Hors J; Schaison G; Seret D
Ann Endocrinol (Paris); 1988; 49(1):17-21. PubMed ID: 2900619
[TBL] [Abstract][Full Text] [Related]
28. Close linkage of MEN2A with RBP3 locus in Japanese kindreds.
Yamamoto M; Takai S; Miki T; Motomura K; Okazaki M; Nishisho I; Tateishi H; Miyauchi A; Honjo T; Pakstis AJ
Hum Genet; 1989 Jun; 82(3):287-8. PubMed ID: 2567278
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia, the old and the new: a mini review.
Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
[TBL] [Abstract][Full Text] [Related]
30. Dermal Hyperneury and Multiple Sclerotic Fibromas in Multiple Endocrine Neoplasia Type 2A Syndrome.
Alegría-Landa V; Jo-Velasco M; Robledo M; Requena L
JAMA Dermatol; 2017 Dec; 153(12):1298-1301. PubMed ID: 29049491
[TBL] [Abstract][Full Text] [Related]
31. An efficient strategy for gene mapping using multipoint linkage analysis: exclusion of the multiple endocrine neoplasia 2A (MEN2A) locus from chromosome 13.
Farrer LA; Goodfellow PJ; Lamarche CM; Franjkovic I; Myers S; White BN; Holden JJ; Kidd JR; Simpson NE; Kidd KK
Am J Hum Genet; 1987 Apr; 40(4):329-37. PubMed ID: 2883889
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
33. Medullary thyroid carcinoma: Australian experience with genetic testing.
Ward JL; Hyland VJ; Andrew DS; Marsh DJ; Robinson BG
Henry Ford Hosp Med J; 1992; 40(3-4):220-3. PubMed ID: 1362409
[TBL] [Abstract][Full Text] [Related]
34. The gene for mannose-binding protein maps to chromosome 10 and is a marker for multiple endocrine neoplasia type 2.
Schuffenecker I; Narod SA; Ezekowitz RA; Sobol H; Feunteun J; Lenoir GM
Cytogenet Cell Genet; 1991; 56(2):99-102. PubMed ID: 1672848
[TBL] [Abstract][Full Text] [Related]
35. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
36. Linkage analysis of multiple endocrine neoplasia type 2A (MEN-2A) and three DNA markers on chromosome 20: evidence against synteny.
Farrer LA; Goodfellow PJ; White BN; Holden JJ; Kidd JR; Simpson NE; Kidd KK
Cancer Genet Cytogenet; 1987 Aug; 27(2):327-34. PubMed ID: 2885081
[TBL] [Abstract][Full Text] [Related]
37. [Multiple endocrine neoplasia syndromes. Type 2].
Juodele L; Juozaityte E; Zindzius A; Pundzius J
Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
[TBL] [Abstract][Full Text] [Related]
38. The gene for MEN 2A is tightly linked to the centromere of chromosome 10.
Narod SA; Sobol H; Schuffenecker I; Lavoué MF; Lenoir GM
Hum Genet; 1991 Mar; 86(5):529-30. PubMed ID: 1673115
[TBL] [Abstract][Full Text] [Related]
39. A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A.
Lichter JB; Hackleman SM; Ponder BA; Easton D; Narod SA; Lenoir GM; Gagel RF; Simpson NE; Gardner E; Goodfellow PJ
Henry Ford Hosp Med J; 1992; 40(3-4):205-9. PubMed ID: 1362406
[TBL] [Abstract][Full Text] [Related]
40. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
